Alnylam Pharmaceuticals
ALNY
#661
Rank
A$47.12 B
Marketcap
$365.35
Share price
-8.44%
Change (1 day)
39.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company